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A B S T R A C T
Introduction. Evidence suggests that painful intercourse, pain-related psychosocial factors, and altered pain pro-
cessing magnify the pain experience, but it is not clear how these factors are related to each other.
Aim. The aims were to (i) characterize differences between women with pelvic pain and pain-free women using a
battery of pain-related psychosocial measures, clinical pain ratings, and evoked local and remote pain sensitivity; and
(ii) examine the relationship between intercourse pain, clinical pain, and local and remote evoked pain sensitivity.
Methods. Women with pelvic pain lasting at least 3 months and pain-free women completed questionnaires and
underwent pain sensitivity testing. Self-report measures included clinical pain intensity, pain catastrophizing, pain-
related fear, pain anxiety, depression, sexual function, and self-efﬁcacy. Pain sensitivity measures included threshold
and tolerance and temporal summation of pain. Separate analyses of variance (anova) were used to test group
differences in self-report and pain sensitivity measures. Correlations were calculated among dyspareunia, psycho-
social factors, and evoked pain.
Main Outcome Measures. Self-reported pain and pain sensitivity measures.
Results. Twenty-eight pain-free women and 14 women with pelvic pain participated in this study. Women with
pelvic pain reported greater pain intensity and greater psychosocial involvement compared with pain-free women.
No differences existed between groups for thermal or pressure measures, but women with pelvic pain rated their pain
with pain testing signiﬁcantly higher than pain-free women. Intercourse pain was signiﬁcantly associated with
affective and sensory pain and pressure pain ratings at the puborectalis, vulvar vestibule, adductor longus tendons,
and tibialis anterior muscle.
Conclusions. Differences in local pain ratings suggest that women with pelvic pain perceive stimuli in this region as
more painful than pain-free women although the magnitude of stimuli does not differ. Alappattu MJ, George SZ,
Robinson ME, Fillingim RB, Moawad N, LeBrun EW, and Bishop MD. Painful intercourse is significantly
associated with evoked pain perception and cognitive aspects of pain in women with pelvic pain. Sex Med
2015;3:14–23.
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Introduction
Despite differences in the etiologies of differ-ent pelvic pain medical diagnoses (i.e.,
endometriosis, vulvodynia, painful bladder syn-
drome, and pelvic inﬂammatory disease, for
example), the overlap of clinical elements of
women with chronic pelvic pain (CPP) makes it
appropriate to group these patients under the
umbrella diagnosis of “chronic pelvic pain.” These
clinical elements include pain with intercourse
(dyspareunia) [1–4], pain during menstruation
(dysmenorrhea) [5,6], and reports of myofascial
pain of the pelvic ﬂoor muscles and proximal soft
tissue [2,7–9]. CPP is further described as nonma-
lignant, continuous or recurrent pain of structures
related to the pelvis, lasting at least 6 months, and
is often associated with negative sexual, cognitive,
and emotional consequences [10]. This condition
is also associated with dysfunction in one or
usually more of the following body systems: gyne-
cological, urological, gastrointestinal, neurologi-
cal, and musculoskeletal [11]. The community
prevalence of CPP is estimated at nearly 15% [12],
and primary care prevalence estimates are compa-
rable with that of low back pain and asthma [13].
The annual economic costs associated with only
one type of CPP, endometriosis, have been esti-
mated at nearly $22 billion [14]. This prevalent,
costly condition is described as a “medical night-
mare” for clinicians [11]. Women with CPP report
depression, anxiety, and sleep disturbances, in
addition to limitations in sexual activity and mobil-
ity [15,16].
Women with CPP also exhibit evidence of pain-
related psychological involvement, including
catastrophizing, fear, and hypervigilance during
intercourse. Payne et al. reported that women with
vulvodynia reported more hypervigilance to pain
during intercourse, suggesting that increased
attention paid to a threat of potentially painful
stimuli during intercourse may interfere with
sexual arousal and diminish the experience of
intercourse [17]. Women with vulvodynia also
report more catastrophizing thoughts related to
intercourse pain compared with nonintercourse
pain [18]. In a survey of women with interstitial
cystitis (IC) [19], a signiﬁcant number of them
with pelvic pain complaints reported fear of pain
with intercourse compared with healthy controls,
in addition to signiﬁcantly higher reports of
dyspareunia. Collectively, these studies suggest
that despite differences in reported etiologies,
women with CPP suffer from painful intercourse
and are potentially inﬂuenced by pain-related psy-
chological factors that likely exacerbate this pain
experience.
In addition to clinical symptoms such as pain
and psychological distress, women with CPP
exhibit increased sensitivity to local and remote
noxious stimuli compared with healthy women
[8,18,20–22]. Granot et al. applied a series of
thermal stimuli to the forearms of women with
vulvodynia and also to healthy women and
reported that heat pain thresholds of women with
vulvodynia were signiﬁcantly lower than those of
healthy women [21]. Additionally, suprathreshold
pain ratings and anxiety scores were signiﬁcantly
higher for the women with vulvodynia. These
results suggest that women with vulvodynia may
have enhanced pain sensitivity, perhaps due in part
to changes in central nervous system-mediated
pain processing. Alterations in central nervous
system processing are believed to contribute to the
maintenance of pain in pelvic pain conditions such
as vulvodynia [21,22], irritable bowel syndrome
[23], and endometriosis [24] and other chronic
pain conditions including ﬁbromyalgia [25,26] and
low back pain [27,28].
Aims
The available literature suggest that reports of
pain and painful intercourse, pain-related psycho-
social factors, and enhanced pain sensitivity
magnify the pain experience, but it is not clear how
these factors are related to each other. In particu-
lar, the relationship between intercourse pain,
local and remote pain sensitivity, and positive and
negative pain-related psychosocial factors is
unclear. Understanding the relationship between
the presence of pain-related psychological factors
and painful intercourse may guide clinical
decision-making when determining which inter-
ventions to use. The aim of this report was to
characterize differences between women with
CPP and women without pain using a comprehen-
sive battery of pain-related psychosocial measures,
nonevoked clinical pain ratings, and evoked local
and remote pain sensitivity. The second aim was to
examine the relationship between intercourse
pain, nonevoked pain ratings, and local and remote
evoked pain sensitivity. We hypothesized that
women with CPP would exhibit signiﬁcantly
higher local and remote evoked pain sensitivity,
higher levels of depression, clinical pain intensity,
sexual dysfunction, pain with intercourse, pain-
related psychological involvement (including
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pain catastrophizing, pain-related fear, and pain
anxiety), and signiﬁcantly lower levels of pain self-
efﬁcacy compared with pain-free women. Last, we
hypothesized that intercourse pain in women with
CPP would be signiﬁcantly positively associated
with local evoked pain sensitivity and ratings,
pain catastrophizing, pain-related fear, and pain
anxiety.
Methods
Participants were recruited via electronic and ﬂyer
advertisements on the University of Florida
campus and University of Florida Health outpa-
tient medical and rehabilitation clinics. All partici-
pants completed a single session where they
completed pain self-report and pain-related psy-
chosocial measures and underwent pain sensitivity
testing. All participants completed this testing
session between days 4 and 20 of their menstrual
cycle. All participants were instructed to abstain
from taking any pain medications (oral or topical)
within 24 hours of the testing session. The Uni-
versity of Florida Institutional Review Board
approved this study, and all participants signed an
Informed Consent Form prior to participation in
this study. Seventy-three pain-free individuals
responded to the advertisements. Of these, two
were excluded for being male, seven did not meet
the eligibility criteria, 16 were screened and eli-
gible to participate but did not complete the ﬁrst
session, and 20 responded to the study after pain-
free recruitment was completed. Twenty women
with CPP responded to the advertisements. Of
these, four did not meet the eligibility criteria, and
two were screened and eligible to participate but
did complete the ﬁrst session.
Inclusion and Exclusion Criteria
Both pain-free women and women with pelvic pain
lasting 3 months or longer were included in this
study. Though the EAU Guidelines for Chronic
Pelvic Pain deﬁne CPP as lasting 6 months or
longer [10], other groups, including the National
Institutes of Health [29] and the Institute of Medi-
cine [30], describe chronic pain as lasting 3 months
or longer. We chose the more liberal of these
timeframes for this study. The inclusion criteria for
the pain-free women included age 18 or older and
no complaints of pelvic pain. The inclusion criteria
forwomenwith pelvic pain included age 18 or older
and primary pelvic pain complaint associated with
one or more of the following diagnoses conﬁrmed
by their physician: CPP, painful bladder syndrome/
IC, vulvodynia, endometriosis, dyspareunia,
dysmenorrhea, coccygodynia, irritable bowel syn-
drome, pelvic inﬂammatory disease, prior pelvic
surgery, and myofascial pain. Exclusion criteria
included sensory loss of the hands or feet, preg-
nancy, never having undergone a gynecological
pelvic examination, and/or currently undergoing
physical therapy for pelvic pain.
Main Outcome Measures
Pain Sensitivity
Quantitative Sensory Testing measures included
both thermal and pressure stimuli, and partici-
pants rated their pain using the 101-point
Numerical Pain Rating Scale (NPRS). Both
thermal and pressure stimuli were used to assess
each participant’s threshold and/or tolerance to
pain. Pain sensitivity testing consisted of two prac-
tice intervals of both thermal and pressure stimuli
followed by a baseline interval with recorded data.
Pain sensitivity measures included thermal thresh-
old and tolerance, pressure threshold, and tempo-
ral sensory summation of pain. All thermal stimuli
were delivered with a thermode controlled by the
Medoc Neurosensory Analyzer (TSA-2001;
Medoc Inc., Ramat Yishai, Israel). The delivered
temperatures ranged from 35 to 51°C.
To assess thermal threshold and tolerance, a
continuous heat stimulus was delivered to the par-
ticipants’ dominant forearm.The stimulus began at
35°C and was increased at a rate of 0.5°C with
subjects terminating the stimulus when the tem-
perature reached pain threshold (“when the sensa-
tion of heat ﬁrst changed from heat to pain”) and
tolerance (when the heat sensation became so
strong the participant could no longer stand to have
the thermode on their skin). Threshold and toler-
ance were measured twice at each testing interval,
and the average threshold and tolerance were cal-
culated. Additionally, thermal stimuli were used to
evaluate temporal summation of pain (TSP).TSP is
a dynamic measure of pain processing thought to
capture the pain modulation ability of the central
nervous system. To assess TSP, a train of six heat
pulses was applied to the glabrous skin of partici-
pants’ dominant foot. An interstimulus interval of
2.5 seconds was used, and the temperature of each
heat pulse ﬂuctuated from a baseline of 35°C to
48°C during each stimulus. The participants were
asked to rate the magnitude of their delayed
(second) pain sensation following each pulse. This
procedure was performed once on the dominant
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foot. These response ratings are believed to be
primarily C-ﬁber mediated.
Pressure pain threshold (PPT) was assessed at
the bilateral internal puborectalis muscles and
upper and lower vulvar vestibule with the use of a
thimble algometer using techniques described by
Zolnoun and colleagues [31]. A handheld
algometer was used to assess PPT at the bilateral
adductor longus tendons, dominant tibialis ante-
rior, and dominant thumb web.
Self-Report Measures
NPRS
The 101-point NPRS evaluates pain intensity
using a scale whose end points are designated as
“0 = no pain sensation” and “100 = the most
intense pain sensation imaginable.” Numerical
rating scales are a valid and reliable clinical
measure to assess pain intensity [32,33]. The
NPRS was used to assess current, least, worst, and
resting pelvic pain and intercourse pain in the last
48 hours and last 7 days.
Short-Form McGill Pain Questionnaire
The Short-Form McGill Pain Questionnaire is a
20-item index that measures pain in the affective,
sensory, and evaluative domains. This valid and
reliable [34,35] measure evaluated the quality of
the participants’ pelvic pain.
Female Sexual Function Index
The Female Sexual Function Index (FSFI) is a
19-item questionnaire that measures sexual func-
tioning in women in six domains: desire, arousal,
lubrication, orgasm, satisfaction, and pain. Total
scores range from 2 to 36 with scores less than
26 indicative of sexual dysfunction. The FSFI
has demonstrated high internal consistency
(Cronbach’s alpha 0.91–0.97) and good test–retest
reliability (r = 0.79–0.90) in women with CPP
[36–38].
Pain Anxiety Symptoms Scale
The Pain Anxiety Symptoms Scale (PASS) is a
20-item self-report measure that evaluates pain-
related fear and anxiety in persons with chronic
pain disorders. The PASS-20 has high internal
consistency (Cronbach’s alpha 0.91) and a stable
factorial structure [39,40].
Pain Catastrophizing Scale
The Pain Catastrophizing Scale (PCS) is a 13-item
scale that measures pain catastrophizing in clinical
and nonclinical populations under three domains:
rumination, magniﬁcation, and helplessness. The
PCS is a reliable and valid measure (Cronbach’s
alpha 0.92) with a stable factorial structure [41,42].
Patient Health Questionnaire
The Patient Health Questionnaire-9 is a nine-
item self-report measure that evaluates the pres-
ence of depressive symptoms. This measure is
valid and sensitive and speciﬁc to depressive symp-
toms [43].
Tampa Scale for Kinesiophobia (TSK-11)
The TSK-11 is an 11-item self-report measure
that assesses elevated pain-related fear beliefs
related to movement or activity. This measure
has good internal consistency (Cronbach’s
alpha = 0.79) and test–retest reliability (intraclass
correlation coefﬁcient = 0.81) [44].
Pain Self-Efficacy Questionnaire (PSEQ)
The PSEQ is a 10-item self-report measure that
assesses one’s ability to perform a variety of activi-
ties, including work, household duties, and social
activities, despite of pain. The PSEQ has a high
internal consistency (Cronbach’s alpha = 0.92) and
good test–retest reliability (r = 0.73) [45].
Statistical Analyses
Statistical analyses were conducted using ibm
spss statistics Version 20 (IBM Corporation,
Armonk, NY, USA). Alpha was set at the 0.05 level
for all analyses. Separate analyses of variance
(anova) were used to test differences between
groups on pain sensitivity measures and self-report
measures. Bivariate correlations were calculated
among intercourse pain, pain-related psychosocial
factors, and evoked pain ratings using Pearson cor-
relation moments.
Sample Size Estimates
Using previously published effect size estimates
for cutaneous pain (effect size = 0.49) from a
similar study protocol in patients with irritable
bowel syndrome [46], alpha of 0.05 and power of
80%, the required sample size to predict differ-
ences in cutaneous pain ranged was 22. To account
for potential dropouts, we planned to enroll an
additional 25% of participants and sought 28 par-
ticipants per group.
Results
Demographic Factors
The average age of the pain-free group (N = 28)
was 29.5 years, and the average age of the CPP
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group (N = 14) was 39.57 years (P = 0.02). The
average duration of pelvic pain was 60.35 months
for the CPP group. The medical diagnoses and
races of the pelvic pain group are listed in Table 1.
Pain Intensity and Quality
As expected, women with CPP reported signiﬁ-
cantly higher current, resting, and intercourse
pain during the last 48 hours and 7 days. The
worst and least pelvic pain reported by the CPP
group during the last 2 and 7 days was also sig-
niﬁcantly higher than the pain-free group (see
Table 2). The CPP group reported signiﬁcantly
higher scores on both the sensory and affective
domains of the McGill Pain Questionnaire (see
Table 2).
Pain-Related Psychosocial Factors
Age was signiﬁcantly positively correlated with
measures of depression, self-efﬁcacy, and sexual
function and included in the comparisons as a
covariate using analyses of covariance (ancova) for
these measures. Women with CPP demonstrated
signiﬁcantly higher pain anxiety, depression,
catastrophizing, and pain-related fear compared
with pain-free women, as well as lower pain self-
efﬁcacy. The CPP group also scored signiﬁcantly
lower on the FSFI, with the average score for the
group on this measure indicative of sexual dysfunc-
tion (see Table 3).
Pain Sensitivity
Age was not signiﬁcantly correlated with any of the
measures of pain sensitivity and therefore not
included in any of the comparisons. Women with
CPP demonstrated no signiﬁcant differences in
PPT at any local or remote sites compared with
pain-free women. However, women with CPP
rated their pain signiﬁcantly higher than pain-free
women at the left puborectalis muscle and the
upper vestibule (P = 0.03 and 0.02, respectively; see
Table 4), indicating that their perception of pain at
these sites was higher. No differences existed
between groups for any of the thermalmeasures but
did approach signiﬁcance for TSSP (see Table 5).
Correlations Between Intercourse Pain with
Psychosocial Factors and Pain Sensitivity inWomen
with CPP
Intercourse pain intensity was signiﬁcantly posi-
tively correlated with both the affective and
sensory domains of the McGill Pain Question-
naire (MPQ). Intercourse pain was also signiﬁ-
Table 1 Demographic information and medical
diagnoses of pelvic pain participants
Participant Medical diagnosis (or diagnoses) Race
1 CPP, dysmenorrhea, endometriosis,
myofascial pain
White
2 CPP, dysmenorrhea, endometriosis White
3 CPP Black
4 CPP, dyspareunia, endometriosis White
5 CPP, myofascial pain Black
6 CPP, myofascial pain White
7 CPP, dysmenorrhea, myofascial pain American
Indian
8 CPP, dyspareunia, IBS, myofascial pain White
9 Dyspareunia Black
10 Painful bladder syndrome White
11 CPP, dysmenorrhea, dyspareunia White
12 CPP, dysmenorrhea, endometriosis,
myofascial pain
White
13 CPP, dysmenorrhea, endometriosis White
14 Dyspareunia, myofascial pain, painful
bladder syndrome
White
CPP = chronic pelvic pain; IBS = irritable bowel syndrome
Table 2 Pain sensitivity and quality
Pain free (SD) Pelvic pain (SD) P value
Current pain 0.00 (0.00) 27.51 (24.58) <0.001*
Current pain at rest 0.00 (0.00) 20.00 (22.19) <0.001*
Least pain 48 hours 0.00 (0.00) 15.28 (15.65) <0.001*
Least pain 7 days 0.11 (0.57) 20.36 (28.09) <0.001*
Least pain at rest 48 hours 0.00 (0.00) 12.50 (14.88) <0.001*
Least pain at rest 7 days 0.36 (0.36) 9.64 (11.97) <0.001*
Worst pain 48 hours 0.00 (0.00) 46.57 (27.26) <0.001*
Worst pain 7 days 1.96 (4.58) 55.50 (32.90) <0.001*
Worst pain at rest 48 hours 0.18 (0.94) 28.29 (22.46) <0.001*
Worst pain at rest 7 days 1.43 (4.35) 45.79 (33.15) <0.001*
Intercourse pain 48 hours 0.82 (2.25) 39.86 (36.91) <0.001*
Intercourse pain 7 days 1.07 (2.52) 39.93 (36.83) <0.001*
MPQ-S 1.57 (2.10) 16.25 (4.58) <0.001*
MPQ-A 0.21 (0.63) 3.64 (3.23) <0.001*
*Indicates significance at 0.05 level
Values are mean (SD)
MPQ = McGill Pain Questionnaire; S = sensory subscale; A = affective subscale; SD = standard deviation
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cantly correlated with pressure pain ratings at the
right puborectalis muscle, lower vestibule, adduc-
tor longus, and tibialis anterior but not with any
other evoked pressure pain ratings (see Table 6).
Interim Analysis of Effect Sizes
Apost hoc decisionwasmade to perform an interim
analysis to calculate effect sizes for local and remote
pain sensitivity measures. In order to detect group
differences in pain sensitivity given the calculated
effect sizes, we would have been required to enroll
140 participants to detect remote site differences
and 548 participants to detect local site differences.
Therefore, we decided to end the current study
with enrollment of 28 healthy participants and 14
participants with pelvic pain.
Discussion
The ﬁrst aim of the current study was to compare
psychosocial factors and local and remote pain
sensitivity in women with and without pelvic pain.
The second aim was to examine the relationships
between intercourse pain, local and remote evoked
pain intensity, and nonevoked subjective pain
intensity. The results of the ﬁrst aim of this study
demonstrated that women with pelvic pain
reported greater pain intensity and greater pain-
related psychosocial involvement compared with
healthy women. The CPP group reported signiﬁ-
cantly higher least, worst, current, intercourse, and
resting pelvic pain compared with women without
pain in a 48-hour and 7-day period. Perhaps the
most surprising of these subjective pain ratings was
the higher resting pain. Increased nociceptive input
associated with activation of the pelvic ﬂoor
muscles duringmovement orwith noxious pressure
to the mucosa overlying these muscles (i.e., during
intercourse) is conceivable in women with pelvic
pain. Higher subjective pain while completely at
rest may indicate that nociceptive input from the
pelvic region is ongoing in women with pelvic pain
and is not always associated with movement or
external noxious stimuli in that region.
Interestingly, the results of the current study do
not fully support our original hypothesis or previ-
ous research [21,22,24,31] that women with pelvic
pain would be more sensitive to heat and pressure
stimuli compared with healthy women; that is, we
expected women with CPP would have lower
thresholds for heat and pressure stimuli. However,
no differences existed between groups for the
thermal measures or any of the local or remote
pressure measures. Though the amount of force
required to reach pressure threshold was consis-
tently lower for women with CPP compared with
Table 3 Pain-related psychosocial distress and sexual
function
Pain free (SD) Pelvic pain (SD) P value
PASS 23.43 (17.97) 43.36 (19.58) 0.002*
PHQ† 1.82 (1.74) 8.21 (5.00) <0.001*
PSEQ† 51.92 (12.26) 40.77 (10.92) 0.006*
PCS 9.21 (9.66) 23.14 (12.40) <0.001*
FSFI† 27.69 (4.95) 21.16 (6.73) 0.001*
TSK-11 15.79 (4.10) 23.14 (4.45) <0.001*
*Indicates significance at the 0.05 level
†After controlling for age. Age fixed at 32.9 in each covariate model
FSFI = Female Sexual Function Index; PASS = Pain Anxiety Symptoms Scale;
PCS = Pain Catastrophizing Scale; PHQ = Patient Health Questionnaire;
PSEQ = Pain Self-Efficacy Questionnaire; SD = standard deviation; TSK-
11 = Tampa Scale of Kinesiophobia
Table 4 Local and remote PPT (in Newtons) and pain ratings (0–100 NPRS)
Pain free
(SD)
Pelvic pain
(SD) P value
Effect
size (r)
Right puborectalis PPT 11.05 (7.37) 9.26 (6.06) 0.45 0.12
Right puborectalis rating 18.57 (18.73) 27.36 (23.53) 0.21 0.20
Left puborectalis PPT 9.06 (8.19) 5.55 (5.39) 0.16 0.22
Left puborectalis rating 17.65 (19.07) 34.96 (26.28) 0.02* 0.36
Upper vestibule PPT 17.70 (8.71) 13.49 (6.09) 0.11 0.25
Upper vestibule rating 11.71 (15.09) 25.35 (25.21) 0.03* 0.33
Lower vestibule PPT 11.70 (7.83) 9.59 (6.60) 0.39 0.14
Lower vestibule rating 17.88 (18.48) 28.25 (26.11) 0.14 0.23
Adductor longus PPT 23.31 (8.74) 19.42 (5.66) 0.14 0.23
Adductor longus rating 17.39 (17.71) 23.75 (21.07) 0.31 0.16
Tibialis anterior PPT 61.03 (18.72) 53.75 (14.77) 0.21 0.20
Tibialis anterior rating 16.43 (3.09) 23.71 (16.36) 0.22 0.19
Thumb web PPT 35.89 (15.54) 28.96 (8.27) 0.13 0.24
Thumb web rating 16.13 (17.54) 22.79 (19.74) 0.27 0.17
*Indicates significance at 0.05 level
Values are mean (standard deviation)
NPRS = Numerical Pain Rating Scale; PPT = Pressure pain threshold; SD = standard deviation
Dyspareunia Related to Pain and Cognitive Factors 19
Sex Med 2015;3:14–23© 2014 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
pain-free women, these differences did not reach
statistical signiﬁcance. Our study did not include a
design speciﬁcally to test sensitivity using standard-
ized stimuli, for example, apply the same pressure
to the pelvic ﬂoor and vestibule of all participants
and ask them to rate that pressure. Because of this,
we are unable to make comments regarding
hyperalgesia. However, there is some evidence to
suggest that women with CPP were more sensitive
to locally applied stimuli. The differences that did
exist between groups were the pain ratings at the
pelvic ﬂoor and vestibule, suggesting that the per-
ception of stimuli applied in the pelvic region was
greater for womenwithCPP even though themag-
nitude of the stimuli did not differ. Another poten-
tial contributing factor was the heterogeneity of the
pelvic pain group. Though the majority of the
group was diagnosed with CPP, medical conditions
with different etiologies (e.g., painful bladder syn-
drome or endometriosis) may also exhibit differ-
ences in local and remote painmodulation.Though
our study was not powered to detect these differ-
ences in the pelvic pain sample, future studies
should consider examining pain modulatory differ-
ences in women with different medical conditions
associated with pelvic pain.
In addition to subjective pain reports and con-
sistent with previous research [17,22,47,48],
womenwith pelvic pain also exhibited greater pain-
related psychosocial involvement with elevated
scores in measures of negative affect. The CPP
group also reported a decreased pain self-efﬁcacy,
which is the ability to effectively function in every-
day activities despite the presence of pain. The
presence of pain-related psychosocial factors such
as anxiety, pain-related fear, and catastrophizing,
for example, are well-established in women with
pelvic pain. The ﬁnding of reduced pain self-
efﬁcacy adds to the previous body of work by sug-
gesting that awomanwithCPPhas less belief in her
in ability to affect or control pain and the impact of
Table 5 Thermal pain threshold and tolerance and pain
ratings
Pain free (SD)
Pelvic pain
(SD) P value
Effect
size (r)
HTh (°C) 43.20 (2.80) 44.19 (2.16) 0.25 0.18
HTh rating 18.23 (21.36) 30.36 (25.82) 0.11 0.25
HTol (°C) 47.81 (1.64) 47.06 (1.18) 0.13 0.23
HTol rating 50.34 (30.29) 49.43 (29.21) 0.93 0.01
TS magnitude 3 (13.80) 9.36 (10.07) 0.05* 0.23
*Indicates significance at 0.05 level
Values are mean (standard deviation)
HTh = heat threshold; HTol = heat tolerance; SD = standard deviation; TS =
temporal summation
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that pain on her function. Thus, the coping abilities
of women with pelvic pain may also contribute to
their pain experience.
The relationship of these psychosocial factors to
clinical symptoms of pelvic pain and potential
impact on sexual activity, including pain with inter-
course and sexual dysfunction, is less clear. We
originally hypothesized signiﬁcant positive associa-
tions between pain sensitivity, psychosocial factors,
and painful intercourse, and our results partially
support this hypothesis. Intercourse pain was sig-
niﬁcantly associated with MPQ affective and
sensory subscales and PPT ratings at the
puborectalis, vulvar vestibule, adductor longus
tendons, and tibialis anterior muscle. The associa-
tion between intercourse pain and both local and
remote sites suggests altered central pain process-
ing. Thus, asking a woman with pelvic pain if she
has pain with intercourse is a potential indicator of
enhanced supraspinal involvement in nociceptive
processing and may provide direction for centrally
acting vs. peripheral treatment. While we do not
believe our ﬁndings to be robust enough to suggest
central vs. peripheral pharmacological interven-
tions, we do agree that the combination of ﬁndings
would represent a woman with more centrally
mediated pain. Intercourse pain was not associated
with any other pain-related psychosocial factors or
pain sensitivity measures. A potential reason for
this lack of an association between intercourse pain
and pain-related psychosocialmeasuresmay be that
the measures were not dyspareunia speciﬁc but
asked about pain in general.
Others have reported a lack of a relationship
between intercourse pain and pain sensitivity mea-
sures. One potential reason for this lack of a rela-
tionship may be the nature of the stimulus used to
experimentally evoke pain. A recent study by
Desrochers et al. [49] examined the relationship of
catastrophizing, hypervigilance, anxiety, pain self-
efﬁcacy, and pain-related fear with intercourse
compared with evoked pain of the vulvar vestibule.
Their results suggested that little correlation
existed between palpation of the vulvar vestibule
and the aforementioned psychosocial variables, to
which the authors contributed to the relatively
nonemotional experience of experimentally
induced pain vs. the highly emotional experience
of intercourse. A potential reason for the associa-
tion between intercourse pain and local evoked
pain shown in our current study compared with
the aforementioned study may be the type of
stimulus used to assess local pain sensitivity.
Digital assessment with a thimble algometer used
in the current study may have more closely mir-
rored sexual activity compared with a cotton swab
applied at the vestibule. Though matching the
emotional experience of intercourse may not be
ideal in an experimental setting, future studies
should consider using stimuli that better represent
painful sexual stimuli.
Limitations
Several limitations exist in the current study. A
signiﬁcant limitation is the heterogeneity in
medical diagnoses of the sample of participants
with pelvic pain. Potential differences in the eti-
ologies of this group may have contributed to the
variability of pain sensitivity at local and remote
sites. Future studies should consider a more
homogenous sample of patients with pelvic pain.
Second, there was large variability of thresholds
and ratings in both pain-free women and women
with CPP. This variability is not unexpected given
known individual differences in the pain experi-
ence but does increase sample size requirements.
This study may have been underpowered to detect
group differences, especially given the smaller
sample size of the pelvic pain group. A second
contributing factor to the high variability may
have been the number of practice sessions.
Though all participants practiced rating their pain
with the thermal and pressure stimuli prior to the
baseline and testing intervals, the practice intervals
occurred within the same session. Practicing the
testing procedures over the several days or sessions
may have helped to reduce this variability by better
preparing participating how to use the rating
systems and accustom them further to the range of
temperatures and pressures that they might expe-
rience during testing.
Another limitation is that the CPP sample in
this study included women with a variety of differ-
ent pelvic pain diagnoses that may or may not have
included pain of the pelvic ﬂoor or vestibule,
which is where the local pressure stimuli were
applied. More focused diagnostic criteria and
physical screening of participants’ pelvic ﬂoor
musculature might be important for future studies
examining pelvic ﬂoor muscle sensitivity in
response to an intervention. Last, though we
instructed women to refrain from taking oral pain
medications or apply any topical analgesics within
24 hours of the testing session, we did not ask
them to refrain from other medications, such as
tricyclic antidepressants, which are used to treat
chronic pain.
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